MX2015005662A - Analogos de insulina de una sola cadena de larga accion. - Google Patents

Analogos de insulina de una sola cadena de larga accion.

Info

Publication number
MX2015005662A
MX2015005662A MX2015005662A MX2015005662A MX2015005662A MX 2015005662 A MX2015005662 A MX 2015005662A MX 2015005662 A MX2015005662 A MX 2015005662A MX 2015005662 A MX2015005662 A MX 2015005662A MX 2015005662 A MX2015005662 A MX 2015005662A
Authority
MX
Mexico
Prior art keywords
insulin
gly
arg
leu
chain
Prior art date
Application number
MX2015005662A
Other languages
English (en)
Spanish (es)
Inventor
Michael Weiss
Original Assignee
Univ Case Western Reserve
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Case Western Reserve filed Critical Univ Case Western Reserve
Publication of MX2015005662A publication Critical patent/MX2015005662A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/62Insulins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/28Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
MX2015005662A 2012-11-05 2013-11-05 Analogos de insulina de una sola cadena de larga accion. MX2015005662A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261722350P 2012-11-05 2012-11-05
PCT/US2013/068585 WO2014071405A2 (en) 2012-11-05 2013-11-05 Long-acting single-chain insulin analogues

Publications (1)

Publication Number Publication Date
MX2015005662A true MX2015005662A (es) 2015-08-20

Family

ID=50628271

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015005662A MX2015005662A (es) 2012-11-05 2013-11-05 Analogos de insulina de una sola cadena de larga accion.

Country Status (15)

Country Link
US (2) US9499600B2 (OSRAM)
EP (1) EP2914620B1 (OSRAM)
JP (1) JP6584953B2 (OSRAM)
KR (1) KR102163936B1 (OSRAM)
CN (2) CN112266414A (OSRAM)
AU (1) AU2013337250B2 (OSRAM)
BR (1) BR112015010194B1 (OSRAM)
CA (1) CA2890719C (OSRAM)
EA (1) EA201590882A1 (OSRAM)
ES (1) ES2694418T3 (OSRAM)
IL (1) IL238651B (OSRAM)
MX (1) MX2015005662A (OSRAM)
PH (1) PH12015500989A1 (OSRAM)
SG (1) SG11201503522RA (OSRAM)
WO (1) WO2014071405A2 (OSRAM)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9624287B2 (en) 2012-07-17 2017-04-18 Case Western Reserve University O-linked carbohydrate-modified insulin analogues
DK2877200T3 (da) * 2012-07-17 2019-08-12 Univ Case Western Reserve O-bundne carbonhydratmodificerede insulinanaloger
WO2015106269A2 (en) 2014-01-13 2015-07-16 Thermalin Diabetes, Llc Rapid action insulin formulations and pharmaceutical delivery systems
CZ308383B6 (cs) * 2014-06-30 2020-07-15 Ústav Organické Chemie A Biochemie Akademie Věd Čr, V.V.I. Derivát inzulinu s cyklickou strukturou v C-konci B-řetězce
US10392429B2 (en) 2014-10-06 2019-08-27 Case Western Reserve University Biphasic single-chain insulin analogues
AR105616A1 (es) 2015-05-07 2017-10-25 Lilly Co Eli Proteínas de fusión
CN108430493A (zh) 2015-12-23 2018-08-21 卡斯西部储备大学 超稳胰岛素类似物在聚合物熔体中的包囊
JP2022507627A (ja) * 2018-11-19 2022-01-18 ケース ウェスタン リザーブ ユニバーシティ ポリ-アラニンc-ドメインのサブセグメントを有する単鎖インスリンアナログ
BR112021011156A2 (pt) 2018-12-11 2021-10-26 Sanofi Conjugados de insulina
TWI844709B (zh) 2019-07-31 2024-06-11 美商美國禮來大藥廠 鬆弛素(relaxin)類似物及其使用方法
JP2023505814A (ja) * 2019-12-10 2023-02-13 サノフイ スルホンアミドとポリペプチドとのコンジュゲートを形成する方法
CN118201954A (zh) 2021-09-20 2024-06-14 克云生物科技股份公司 精氨酸酶-胰岛素融合蛋白

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60104069T2 (de) * 2000-10-02 2005-08-25 Yonsei University Einkettige Insulinanaloge
KR100449454B1 (ko) * 2000-10-02 2004-09-21 이현철 단일사슬 인슐린 유도체의 유전자를 포함하는 당뇨병치료용 벡터
AU2004234345A1 (en) * 2003-04-29 2004-11-11 Eli Lilly And Company Insulin analogs having protracted time action
KR100508616B1 (ko) * 2003-06-20 2005-08-17 신항철 염기성 아미노산 첨가를 통한 활성이 증가된 단일사슬 인슐린 아날로그
AU2004295023A1 (en) * 2003-12-03 2005-06-16 Novo Nordisk A/S Single-chain insulin
ES2554773T3 (es) * 2006-10-04 2015-12-23 Case Western Reserve University Insulina y análogos de la insulina resistentes a la fibrilación
KR20110021758A (ko) * 2008-04-22 2011-03-04 케이스 웨스턴 리저브 유니버시티 이형체-특이적 인슐린 유사체
WO2011003820A1 (de) * 2009-07-06 2011-01-13 Sanofi-Aventis Deutschland Gmbh Hitze- und schüttelstabile insulinzubereitungen
KR101853606B1 (ko) * 2009-07-06 2018-05-03 사노피-아벤티스 도이칠란트 게엠베하 메티오닌을 함유하는 수성 인슐린 제제
US8399407B2 (en) 2009-09-17 2013-03-19 Case Western Reserve University Non-standard insulin analogues
CN104010652A (zh) * 2011-10-27 2014-08-27 卡斯西部储备大学 超浓缩的速效胰岛素类似物制剂
CN104168911A (zh) * 2012-01-20 2014-11-26 卡斯西部储备大学 谷氨酸-稳定的胰岛素类似物
WO2014052451A2 (en) * 2012-09-26 2014-04-03 Indiana University Research And Technology Corporation Insulin analog dimers

Also Published As

Publication number Publication date
CN105008395A (zh) 2015-10-28
WO2014071405A3 (en) 2014-08-21
EP2914620B1 (en) 2018-08-08
EP2914620A4 (en) 2016-05-25
IL238651B (en) 2020-03-31
EP2914620A2 (en) 2015-09-09
SG11201503522RA (en) 2015-06-29
US20170137488A1 (en) 2017-05-18
US9975940B2 (en) 2018-05-22
WO2014071405A2 (en) 2014-05-08
US9499600B2 (en) 2016-11-22
CN105008395B (zh) 2020-12-29
KR20150096387A (ko) 2015-08-24
CN112266414A (zh) 2021-01-26
IL238651A0 (en) 2015-06-30
KR102163936B1 (ko) 2020-10-13
JP6584953B2 (ja) 2019-10-02
AU2013337250B2 (en) 2017-06-22
CA2890719A1 (en) 2014-05-08
JP2016506366A (ja) 2016-03-03
US20150274803A1 (en) 2015-10-01
CA2890719C (en) 2023-02-14
PH12015500989A1 (en) 2015-07-13
ES2694418T3 (es) 2018-12-20
BR112015010194B1 (pt) 2022-03-22
EA201590882A1 (ru) 2015-09-30
BR112015010194A2 (pt) 2017-12-12

Similar Documents

Publication Publication Date Title
US9975940B2 (en) Long-acting single-chain insulin analogues
US11142560B2 (en) Biphasic single-chain insulin analogues
US11174303B2 (en) Single-chain insulin analogues stabilized by a fourth disulfide bridge
AU2013337250A1 (en) Long-acting single-chain insulin analogues
EP3883957A1 (en) Single-chain insulin analogues with poly-alanine c-domain sub-segments
WO2016105545A2 (en) Insulin analogues with enhanced stabilized and reduced mitogenicity
AU2014232894B2 (en) Site 2 insulin analogues
CA2964918A1 (en) Halogenated insulin analogues of enhanced biological potency
BR112021005366A2 (pt) análogo de insulina de cadeia simples, uso deste e método para reduzir o açúcar no sangue de um paciente
HK40045373A (en) Long-acting single-chain insulin analogues
HK1238651A1 (en) Biphasic single-chain insulin analogues